Collaborations that uncovered the underlying genetic and cellular causes of specific immune disorders have, in some cases, resulted in novel treatments. Two such novel treatments are being actively investigated through a clinical treatment trial at NIH:
- Study of Efficacy of CDZ173 in Patients With PASLI/APDS, NCT02435173
- Study of Pozelimab to treat CHAPLE disease, NCT04209634